Clinical Trial Update: Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update reports results for EVP 1001-1 (SeeMore) evaluating myocardial viability in patients with ischemic cardiomyopathy; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy

Drugs mentioned

• SeeMore

Snippet

Sponsor: Stanford University | Conditions: ISCHEMIC CARDIOMYOPATHY | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-01-02